Cassava Sciences Inc (SAVA)
22.08
-1.04
(-4.50%)
USD |
NASDAQ |
May 20, 16:00
22.08
0.00 (0.00%)
After-Hours: 20:00
Cassava Sciences Free Cash Flow (Quarterly): -19.13M for March 31, 2024
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | -19.13M |
December 31, 2023 | -22.36M |
September 30, 2023 | -26.55M |
June 30, 2023 | -19.92M |
March 31, 2023 | -13.61M |
December 31, 2022 | -20.98M |
September 30, 2022 | -22.71M |
June 30, 2022 | -12.58M |
March 31, 2022 | -23.96M |
December 31, 2021 | -8.087M |
September 30, 2021 | -36.80M |
June 30, 2021 | -5.212M |
March 31, 2021 | -2.306M |
December 31, 2020 | -1.175M |
September 30, 2020 | -2.171M |
June 30, 2020 | -0.842M |
March 31, 2020 | -1.194M |
December 31, 2019 | -0.589M |
September 30, 2019 | -0.73M |
June 30, 2019 | -0.591M |
March 31, 2019 | -0.622M |
December 31, 2018 | -0.565M |
September 30, 2018 | -1.436M |
June 30, 2018 | -1.126M |
March 31, 2018 | -1.643M |
Date | Value |
---|---|
December 31, 2017 | -1.437M |
September 30, 2017 | -2.151M |
June 30, 2017 | -3.197M |
March 31, 2017 | -1.452M |
December 31, 2016 | -3.03M |
September 30, 2016 | -2.863M |
June 30, 2016 | -3.274M |
March 31, 2016 | -3.142M |
December 31, 2015 | -3.548M |
September 30, 2015 | -2.41M |
June 30, 2015 | -1.948M |
March 31, 2015 | -1.342M |
December 31, 2014 | -2.564M |
September 30, 2014 | -1.672M |
June 30, 2014 | -2.591M |
March 31, 2014 | -2.802M |
December 31, 2013 | -1.454M |
September 30, 2013 | -1.819M |
June 30, 2013 | -1.801M |
March 31, 2013 | -1.873M |
December 31, 2012 | -1.854M |
September 30, 2012 | -1.297M |
June 30, 2012 | -1.95M |
March 31, 2012 | -2.07M |
December 31, 2011 | -0.809M |
Free Cash Flow Definition
Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.
Free Cash Flow (Quarterly) Range, Past 5 Years
-36.80M
Minimum
Sep 2021
-0.589M
Maximum
Dec 2019
-12.07M
Average
-10.33M
Median
Free Cash Flow (Quarterly) Benchmarks
Amylyx Pharmaceuticals Inc | -0.556M |
ACADIA Pharmaceuticals Inc | 29.08M |
Vertex Pharmaceuticals Inc | 1.058B |
Cormedix Inc | -17.37M |
Oragenics Inc | -3.064M |